Results 81 to 90 of about 1,268 (176)
Identifying newborns at risk for cystic fibrosis (CF) by newborn screening (NBS) using dried blood spot (DBS) specimens provides an opportunity for presymptomatic detection. All NBS strategies for CF begin with measuring immunoreactive trypsinogen (IRT).
Ilham Sadik +10 more
doaj +1 more source
Exploring Turkey's mosaic of novel variants and complex alleles in cystic fibrosis genetics
Abstract Backgrounds Genetic variants in CF transmembrane conductance regulator (CFTR) gene causes cystic fibrosis (CF), a prevalent autosomal recessive disorder. More than 2000 variants in CFTR have been described as disease causative. This study aims to delineate the genotypic and phenotypic landscape of CF among people with CF (pwCF) followed at the
Ceren Ayça Yıldız +16 more
wiley +1 more source
Trypsin activity. A new marker of acute alcoholic pancreatitis [PDF]
A normal serum amylase level is found in up to 32% of patients with acute alcoholic pancreatitis. This underlines the need for more sensitive diagnostic tests in this frequent cause of pancreatitis.
Michel Cremer +11 more
core +1 more source
Pancreas and pancreatitis: Exocrine pancreatic insufficiency
Abstract Exocrine pancreatic insufficiency (EPI) is highly prevalent among individuals with cystic fibrosis (CF). Individuals diagnosed with EPI are often labeled as having “pancreas insufficient cystic fibrosis (PI‐CF)” while those with normal exocrine function are labeled as “pancreas sufficient CF (PS‐CF).” This diagnosis of EPI relies on clinical ...
Mitchell L. Ramsey, Gary J. Galante
wiley +1 more source
Abstract Acute pancreatitis (AP) is a common gastrointestinal disease with high morbidity and mortality rate. Unfortunately, neither the etiology nor the pathophysiology of AP are fully understood and causal treatment options are not available. Recently we demonstrated that heparanase (Hpa) is adversely involved in the pathogenesis of AP and inhibition
Dalit B. Hamo‐Giladi +8 more
wiley +1 more source
Characterization of immunoreactive trypsinogen activation peptide in urine in acute pancreatitis.
All work on human trypsinogen activation peptide (TAP) in acute pancreatitis has been carried out with the same assay. Despite the extensive use of this original TAP assay, there is no characterization of the TAP-like immunoreactivity measured.The aims of this study were to develop an additional TAP assay and to attempt to characterize the TAP-like ...
Ulf, Petersson, Anders, Borgström
openaire +1 more source
Abstract Background Cystic fibrosis (CF) is a life‐shortening multisystem genetic disease. Although progressive pulmonary disease is the predominant cause of morbidity and mortality, improvements in treatment for CF‐related lung disease, with associated increase in longevity, have increased the prevalence of extrapulmonary manifestations1.
Jonathan E. M. O'Donnell +32 more
wiley +1 more source
Newborn cystic fibrosis screening in southeastern Mexico: Birth prevalence and novel CFTR gene variants [PDF]
Objective To use the results of the first five years of a cystic fibrosis newborn screening program to estimate the cystic fibrosis birth prevalence and spectrum of cystic fibrosis transmembrane conductance regulator ( CFTR) gene variants in Yucatan ...
Claudia-Margarita Moreno-Graciano +10 more
core +1 more source
Immunoreactive trypsin(Ogen) in the sera of children with recent-onset insulin-dependent diabetes and matched controls [PDF]
To evaluate the exocrine pancreatic function at the time of diagnosis of insulin-dependent diabetes mellitus, we determined immunoreactive an-odal and cathodal trypsin(ogen) levels in sera from almost all children (n = 375) 0-14 years of age in Sweden in
Kockum, K. +50 more
core +3 more sources
Impact of heparanase‐2 (Hpa2) on cancer and inflammation: Advances and paradigms
(A) Clinical evidence in several types of cancer shows that Hpa2 is readily detected in normal epithelium, whereas its levels are decreased substantially in the resulting carcinomas. Importantly, patients exhibiting high levels of Hpa2 survived longer than patients showing low levels of Hpa2.
Israel Vlodavsky +4 more
wiley +1 more source

